SCHEMBL20132376

SCHEMBL20132376

COc1ccc(F)cc1CNc1ccc(C(=O)NO)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 5/20 0.62
HDAC6 Q9UBN7 7/20 0.59
HDAC1 Q13547 6/20 0.59
HDAC3 O15379 3/20 0.59
HDAC2 Q92769 3/20 0.59
HDAC8 Q9BY41 2/20 0.54
HIF1A Q16665 3/20 0.53
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 1/20 0.52
USP2 O75604 1/20 0.52
ALDH1A1 P00352 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
THRB P10828 1/20 0.52
ALOX15 P16050 1/20 0.52
CASP1 P29466 1/20 0.52
HTT P42858 1/20 0.52
RECQL P46063 1/20 0.52
BLM P54132 1/20 0.52
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20132377 0.87 HIF1A (0.65) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL20132422 0.87 HIF1A (0.65) NTRK1HIF1AKDM4EMEN1USP2
SCHEMBL20132381 0.86 HDAC1 (0.58) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL20132378 0.84 HDAC1 (0.54) NTRK1HDAC6HDAC1HDAC3HDAC2
SCHEMBL31005965 0.77 NTRK1 (1.00) NTRK1
SCHEMBL31005980 0.77 NTRK1 (0.85) NTRK1
SCHEMBL30690063 0.75 HDAC1 (0.72) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL4730175 0.74 HDAC3 (1.00) HDAC6HDAC1HDAC3HDAC2
SCHEMBL20132420 0.74 CA1 (0.76) HIF1AKDM4EMEN1USP2ALDH1A1
SCHEMBL12971594 0.73 HIF1A (0.57) HIF1AKDM4EMEN1USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538084-B1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS ACETYLON PHARMACEUTICALS INC (US) 2023-11-01 EP disclosed
US-10927072-B2 Phenyl and pyridinyl hydroxamic acids ACETYLON PHARMACEUTICALS, INC. (US) 2021-02-23 US disclosed
US-10370324-B2 Phenyl and pyridinyl hydroxamic acids ACETYLON PHARMACEUTICALS, INC. (US) 2019-08-06 US disclosed
US-20180127356-A1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS ACETYLON PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370324-B2 Phenyl and pyridinyl hydroxamic acids HDAC6, HDAC1, HDAC5 NTRK1 3379/4885HDAC6 1/4885HDAC1 2/4885
US-10927072-B2 Phenyl and pyridinyl hydroxamic acids HDAC6, HDAC1, HDAC5 NTRK1 3379/4885HDAC6 1/4885HDAC1 2/4885
US-20180127356-A1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS HDAC6, HDAC1, HDAC5 NTRK1 3379/4885HDAC6 1/4885HDAC1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.